At a glance
Company snapshot
Green Thumb Industries is a Chicago-based public cannabis company combining branded consumer products with RISE Dispensaries. Founded in 2014, it reported operations in 14 regulated U.S. markets, approximately 4,900 employees and more than 120 RISE locations in August 2026. Products are manufactured and sold within separate state systems.
Founder and early history
Ben Kovler founded Green Thumb in 2014 and remains founder, chairman and chief executive. The company began operating in 2015 after receiving Illinois medical-cannabis cultivation, processing and retail licenses. It listed subordinate voting shares on the Canadian Securities Exchange in 2018 and trades in the United States on OTCQX.
RISE retail network
RISE is Green Thumb’s national dispensary banner. Stores serve medical patients, adult-use customers or both depending on the state, and carry Green Thumb products alongside licensed third-party brands. The retail network gives the company direct menu and customer data, but store counts, access rules and product availability change with openings, acquisitions and state regulation.
Consumer brand portfolio
The portfolio includes RYTHM, &Shine, Beboe, Dogwalkers, Doctor Solomon’s, Good Green and incredibles. Together they cover flower, pre-rolls, vapes, concentrates, gummies, chocolates and wellness products. A parent-company listing does not mean every brand or format is produced in all 14 markets; each state requires its own licensed supply chain.
The 2025 IP transaction
On August 27, 2025, Green Thumb sold intellectual-property rights for RYTHM, Beboe, Dogwalkers, Doctor Solomon’s, &Shine and Good Green to Agrify Corporation for $50 million, while taking a license to continue using those brands. Green Thumb was also a significant Agrify shareholder and extended a $45 million secured convertible loan, making the transaction more complex than a simple brand divestiture.
How the model works now
Green Thumb continues to manufacture and distribute licensed brands and owns the RISE retail platform. Its second-quarter 2026 filing records brand-license fees and identifies some consumer products as licensed. Readers should therefore distinguish ownership of a trademark from cultivation, manufacturing, distribution and retail operations, which can remain with Green Thumb under agreement.
Current scale and results
For the quarter ended June 30, 2026, Green Thumb reported $306.7 million in revenue, $4.9 million in GAAP net income and $29 million in operating cash flow. It said growth came partly from Minnesota adult-use sales and existing markets including Connecticut, Florida and Ohio. These are dated financial results, not projections.
Recognition and social impact
The company’s August 2026 release says it was named to TIME’s America’s Best Companies 2026 list as the highest-ranked cannabis company. Green Thumb also publishes a separate social-impact report covering community investment, restorative justice and workforce initiatives. Rankings and company-reported impact totals should be read with their original methodology.
Why Green Thumb matters. Green Thumb is one of the clearest examples of the U.S. multistate model: state-licensed production, a national retail banner and a portfolio designed for different price points and occasions. The 2025 IP sale adds a newer layer, separating brand ownership from ongoing operations. A current profile must track both the physical cannabis business and the licensing relationships behind the names on shelf.